Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer NCT00601406 Breast Cancer
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Primary Periton...
Prostate Cancer
Sarcoma
Vaginal Cancer
Vulvar Cancer
gene expression...
gene rearrangem...
polymorphism an...
laboratory biom...
radiation thera...
- National Cancer Institute (NCI) View Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer NCT00964626 Ovarian Cancer
cisplatin
paclitaxel
18 Years - 72 Years National Cancer Institute (NCI) View Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT02122185 Brenner Tumor
Malignant Ascit...
Malignant Pleur...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Mixed E...
Ovarian Serous ...
Ovarian Undiffe...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Primar...
metformin hydro...
placebo
Chemotherapy
18 Years - University of Chicago View Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers NCT01846520 Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center View Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) NCT00562640 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
filgrastim
therapeutic aut...
cyclophosphamid...
laboratory biom...
18 Years - 120 Years Memorial Sloan Kettering Cancer Center View Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck NCT00063895 Recurrent Non-s...
Recurrent Ovari...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IIIA Non-...
Stage IIIA Ovar...
Stage IIIB Non-...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
erlotinib hydro...
pharmacological...
pharmacogenomic...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer NCT02082470 Cancer Survivor
Stage IA Ovaria...
Stage IB Ovaria...
Stage IC Ovaria...
Stage IIA Ovari...
Stage IIB Ovari...
Stage IIC Ovari...
Stage IIIA Ovar...
Stage IIIB Ovar...
Stage IIIC Ovar...
follow-up care
active surveill...
questionnaire a...
21 Years - City of Hope Medical Center View Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer NCT01927393 Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Stage III Pancr...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
palliative care
educational int...
quality-of-life...
questionnaire a...
telephone-based...
21 Years - City of Hope Medical Center View Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer NCT02082470 Cancer Survivor
Stage IA Ovaria...
Stage IB Ovaria...
Stage IC Ovaria...
Stage IIA Ovari...
Stage IIB Ovari...
Stage IIC Ovari...
Stage IIIA Ovar...
Stage IIIB Ovar...
Stage IIIC Ovar...
follow-up care
active surveill...
questionnaire a...
21 Years - City of Hope Medical Center View Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies NCT00335998 Recurrent Cervi...
Recurrent Ovari...
Recurrent Vagin...
Recurrent Vulva...
Stage III Vagin...
Stage IIIA Cerv...
Stage IIIA Ovar...
Stage IIIA Vulv...
Stage IIIB Cerv...
Stage IIIB Ovar...
Stage IIIB Vulv...
Stage IIIC Ovar...
Stage IIIC Vulv...
Stage IV Ovaria...
Stage IVA Cervi...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Vagin...
triapine
laboratory biom...
external beam r...
brachytherapy
cisplatin
pharmacological...
18 Years - National Cancer Institute (NCI) View CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen NCT00305838 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
tamoxifen citra...
diagnostic labo...
- National Cancer Institute (NCI) View Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer NCT00964626 Ovarian Cancer
cisplatin
paclitaxel
18 Years - 72 Years National Cancer Institute (NCI) View Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00838656 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
carboplatin
gemcitabine hyd...
paclitaxel
18 Years - 75 Years National Cancer Institute (NCI) View Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer NCT00601406 Breast Cancer
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Primary Periton...
Prostate Cancer
Sarcoma
Vaginal Cancer
Vulvar Cancer
gene expression...
gene rearrangem...
polymorphism an...
laboratory biom...
radiation thera...
- National Cancer Institute (NCI) View Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer NCT00900289 Ovarian Cancer
DNA methylation...
microarray anal...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Cancer Research UK, Glasgow View Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer NCT00075712 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
carboplatin
paclitaxel
adjuvant therap...
conventional su...
neoadjuvant the...
18 Years - National Cancer Institute (NCI) View Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer NCT00004876 Ovarian Cancer
carboplatin
thalidomide
18 Years - National Cancer Institute (NCI) View Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer NCT00900289 Ovarian Cancer
DNA methylation...
microarray anal...
polymerase chai...
immunohistochem...
laboratory biom...
18 Years - Cancer Research UK, Glasgow View Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer NCT00388037 Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
sunitinib malat...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer NCT01212887 Breast Cancer
Colorectal Canc...
Gastric Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Canc...
Unspecified Adu...
MFE23 scFv-expr...
aldesleukin
cyclophosphamid...
fludarabine pho...
laboratory biom...
pharmacological...
18 Years - Cancer Research UK View CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen NCT00305838 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
tamoxifen citra...
diagnostic labo...
- National Cancer Institute (NCI) View CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen NCT00305838 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
tamoxifen citra...
diagnostic labo...
- National Cancer Institute (NCI) View Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer NCT00986206 brca1 Mutation ...
brca2 Mutation ...
Ovarian Cancer
Biomarker LPA a...
18 Years - 95 Years Women and Infants Hospital of Rhode Island View Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission NCT00693342 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
immunological a...
polyvalent anti...
18 Years - 120 Years GOG Foundation View Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer NCT00303888 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
docetaxel
idronoxil
placebo
18 Years - 120 Years Yale University View Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer NCT01764802 Ovarian Sarcoma
Ovarian Stromal...
Stage I Uterine...
Stage I Vaginal...
Stage I Vulvar ...
Stage IA Cervic...
Stage IA Endome...
Stage IA Fallop...
Stage IA Ovaria...
Stage IA Ovaria...
Stage IA Primar...
Stage IB Cervic...
Stage IB Endome...
Stage IB Fallop...
Stage IB Ovaria...
Stage IB Ovaria...
Stage IB Primar...
Stage IC Fallop...
Stage IC Ovaria...
Stage IC Ovaria...
Stage IC Primar...
Stage II Endome...
Stage II Gestat...
Stage II Uterin...
Stage II Vagina...
Stage II Vulvar...
Stage IIA Cervi...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Cervi...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Prima...
Stage IIC Fallo...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Prima...
Stage III Gesta...
Stage III Uteri...
Stage III Vagin...
Stage III Vulva...
Stage IIIA Cerv...
Stage IIIA Endo...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIB Cerv...
Stage IIIB Endo...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Endo...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Prim...
Breast Cancer
behavioral, psy...
behavioral, psy...
21 Years - 80 Years Ohio State University Comprehensive Cancer Center View Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00897039 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
flow cytometry
immunohistochem...
- National Cancer Institute (NCI) View Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) NCT00562640 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
filgrastim
therapeutic aut...
cyclophosphamid...
laboratory biom...
18 Years - 120 Years Memorial Sloan Kettering Cancer Center View Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer NCT02082470 Cancer Survivor
Stage IA Ovaria...
Stage IB Ovaria...
Stage IC Ovaria...
Stage IIA Ovari...
Stage IIB Ovari...
Stage IIC Ovari...
Stage IIIA Ovar...
Stage IIIB Ovar...
Stage IIIC Ovar...
follow-up care
active surveill...
questionnaire a...
21 Years - City of Hope Medical Center View Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck NCT00063895 Recurrent Non-s...
Recurrent Ovari...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage IIIA Non-...
Stage IIIA Ovar...
Stage IIIB Non-...
Stage IIIB Ovar...
Stage IIIC Ovar...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
erlotinib hydro...
pharmacological...
pharmacogenomic...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer NCT00483782 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
bevacizumab
carboplatin
paclitaxel
questionnaire a...
study of socioe...
quality-of-life...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer NCT00045461 Fallopian Tube ...
Ovarian Cancer
Primary Periton...
carboplatin
ifosfamide
hyperthermia tr...
18 Years - 65 Years National Cancer Institute (NCI) View Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer NCT00986206 brca1 Mutation ...
brca2 Mutation ...
Ovarian Cancer
Biomarker LPA a...
18 Years - 95 Years Women and Infants Hospital of Rhode Island View